Wolverine World Wide

Showing 1885 articles
Business

Beyond the Drill Bit: How EQT Powers the AI Boom and Grid Reliability

As AI data centers drive an unprecedented surge in U.S. power demand, natural gas producer EQT is positioning itself as a critical pillar of energy security. Its proven operational resilience during extreme weather events underscores a strategic shift from a pure commodity play to an essential infrastructure partner.

Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Business

CSL's 34% Plunge: A Buying Opportunity or a Value Trap?

After a bruising year that saw its shares tumble by a third, biotech giant CSL is back in the spotlight. We delve beyond the headline numbers, examining valuation models and market sentiment to assess if the sell-off has created a compelling entry point for long-term investors.

Business

Barclays Shares Surge 68% in a Year: Is the Rally Justified?

Barclays' stock has delivered a stellar 68% total return to shareholders over the past year, fueled by strong revenue and profit figures. As the share price approaches analyst targets, investors are weighing whether the current valuation still offers value or if the easy gains have been made.